Establishing a Pharmacy-Based Pre-Exposure Prophylaxis Program for Young Women Who Sell Sex: Protocol for a Randomized Controlled Trial
JMIR Research Protocols · 2025
DOI: 10.2196/74141 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Oppah Kuguyo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sexual and Reproductive Health, Centre for Sexual Health HIV/AIDS Research Zimbabwe, Harare, Zimbabwe. Hauptthemen laut MEDLINE: HIV Infections, Pre-Exposure Prophylaxis, Sex Workers. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS.
Abstract (Originalsprache)
Background
Sex workers (SWs) are at risk of acquiring HIV infections. Despite this, SWs have low uptake of relevant preventive measures, such as HIV pre-exposure prophylaxis (PrEP). Community-based programs that make PrEP convenient and accessible have the potential to drive PrEP continuation and reduce HIV risk.
Objective
This study aims to describe the co-development and piloting of the Together Optimizing PrEP Access in Zimbabwe (TOPAZ) intervention—where SWs have the opportunity to access PrEP refills through pharmacies in Zimbabwe.
Methods
Using a participatory process, the TOPAZ intervention will be collaboratively developed with pharmacy owners and SWs. TOPAZ comprises the provision of safe and convenient spaces for PrEP refill pickups bundled with a gift voucher incentive at pharmacies. Formative research comprising focus group discussions and in-depth interviews with SWs, pharmacists, and stakeholders will inform the development of the preliminary model (aim 1). A cluster-randomized pilot trial will evaluate the impact of the PrEP-in-pharmacy intervention, compared to standard clinic-based pickup in the key populations program, on PrEP retention at 3, 6, 9, and 12 months after initiation (aim 2). The outcome of the pilot trial will be a comparison of PrEP retention at 6 months after initiation between study arms. We will also compare PrEP retention among SWs aged between 18 and 24 years at 6 months and among participants remaining active in sex work at 6 months. We will use the Generalized Estimation Equations model to generate risk differences and 95% CIs for PrEP retention in intervention versus comparison arms. Analysis will follow an intent-to-treat approach. Finally, a mixed methods study will be conducted to understand the potential for scaling TOPAZ for SWs; insights from this study will inform the design of a future effectiveness trial (aim 3). Proctor’s implementation outcomes, namely, acceptability, adoption, appropriateness, feasibility, fidelity, and penetration of the pharmacy-based PrEP refill program, will be evaluated by triangulation of program data and qualitative interviews.
Results
This study began the enrollment of participants in March 2024. Data collection ended in May 2025. The final comprehensive analysis of the results will be conducted in February 2026 after all the data have been collected and reviewed comprehensively.
Conclusions
This study will report on the feasibility, acceptability, and effectiveness of pharmacy-based PrEP refills to improve PrEP continuation among women who sell sex. If successful, this preliminary study will pave the way for a future effectiveness trial to evaluate this intervention more comprehensively. Trial Registration ClinicalTrials.gov NCT06348069; https://clinicaltrials.gov/study/NCT06348069 International Registered Report Identifier (IRRID) DERR1-10.2196/74141
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Sexual and Reproductive Health, Centre for Sexual Health HIV/AIDS Research Zimbabwe, Harare, Zimbabwe.
- School of Public Health, University of California, Berkeley, Berkeley, CA, United States.
- University of California, San Francisco, San Francisco, United States.
- Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
ORCID-Profile: Oppah Kuguyo, Helena Archer, Lance Azizi, Constancia Watadzaushe, Sharon Munhenzva, Kudzai Chidhanguro, Albert Takaruza, Sithembile Musemburi, Laura Packel, Jenny Liu, Primrose Matambanadzo, Frances M Cowan, Sandra McCoy, Euphemia L Sibanda
Förderung
- NIMH NIH HHS
Zitieren
APA
Kuguyo, O., Archer, H., Azizi, L., Watadzaushe, C., Munhenzva, S., Chidhanguro, K., Takaruza, A., Musemburi, S., Packel, L., Liu, J., Matambanadzo, P., Cowan, F. M., McCoy, S., & Sibanda, E. L. (2025). Establishing a Pharmacy-Based Pre-Exposure Prophylaxis Program for Young Women Who Sell Sex: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/74141
Vancouver
Kuguyo O, Archer H, Azizi L, Watadzaushe C, Munhenzva S, Chidhanguro K, et al. Establishing a Pharmacy-Based Pre-Exposure Prophylaxis Program for Young Women Who Sell Sex: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 2025. doi:10.2196/74141
BibTeX
@article{Kuguyo2025,
author = {Kuguyo, Oppah and Archer, Helena and Azizi, Lance and Watadzaushe, Constancia and Munhenzva, Sharon and Chidhanguro, Kudzai and Takaruza, Albert and Musemburi, Sithembile and Packel, Laura and Liu, Jenny and Matambanadzo, Primrose and Cowan, Frances M and McCoy, Sandra and Sibanda, Euphemia L},
title = {Establishing a Pharmacy-Based Pre-Exposure Prophylaxis Program for Young Women Who Sell Sex: Protocol for a Randomized Controlled Trial},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/74141}
}
EUVIMED